RM

Chapter 1

Pharmacology: study of the actions of drugs and their effects on a living organism.

Neurpharmacology: study of drug-induced changes in nervous system cell functioning. Study of drug actions and their effects on living organisms.

Psychopharmacology: emphasizes drug-induced changes in mood, thinking, and behaviour.

Neuropsychopharmacology: identifies chemical agents that act on the nervous system to change behaviour affected by injury, disease, and environmental factors.

Psychoactive drug: a chemical substance that crosses the blood-brain barrier and acts primarily upon the CNS, where it alters brain function, resulting in changes in behaviour.

Drug Action: specific molecular changes produced by a drug when it binds to a particular target site or receptor.

Drug Effects: Alterations in physiological or psychological functions associated with a specific drug.


Textbook

Placebo Effect

Placebo: A Substance that is pharmacologically inert, yet in many instances produces both therapeutic and side effects.

  • Belief in a drug may produce real physiological effects despite the lack of chemical activity.

    • Such as: gastric acid secretion, blood vessel dilation, and hormonal changes.

Double-blind experiment: Type of experiment in which neither the patient nor the observer knows the treatment received by the patient.


Four Names of Drugs

  • The chemical name

    • identifies the drug molecules and how they are joined together.

    • derived from organic chemistry.

    • e.g., 7-chloro-1,3-dihydro-1-methyl-3-phenyl-2H-1,4-
      benzodiazepin-2-one

  • Generic/Nonproprietary Name

    • official legal name of the drug

    • resembles the chemical name

    • conventions: barbiturates end in -al (e.g., secobarbital); local anesthetics and in -caine (e.g., procaine)

    • First letter is not capitalized (e.g., diazepam)

    • e.g., SKF 10,47 or RU 486

  • Trade/Brand Name

    • aka: brand name or proprietary name

    • describes the formulation (active ingredients & excipients)

    • used by the medical profession (e.g., Valium, Prozac; first letter capitalized)

    • patented

    • One drug can have many different trade names (after the patent expires), and other drug companies can sell it.

    • active ingredients in the drug.

    • different fillers (colour)

  • Street Name

  • Unofficial/slang name applied by users

  • many

  • regional and temporal

  • cannabis/marijuana — weed, boo, gigglewee, mu, hemp, kif, ganga, pot

  • Oxycotin= oxies, Percocets= percs

  • MDMA= E


Classification by Behavioural Impact

Psychoactive Drugs

CNS stimulants: Amphetamine, cocaine, nicotine

  • Produce increased behavioural arousal, alertness, and sense of well-being in the individual.

CNS depressants: Barbiturates, alcohol,

  • include a variety of drugs that depress CNS function and behaviour to cause a sense of relaxation and drowsiness.

  • Some of the sedative-hypnotics are useful for their sedating qualities and for their ability to induce sleep.

Analgesics: Morphine and codeine

  • frequently have CNS-depressant qualities, although their principal effect is to reduce the perception of pain.

  • The most important drugs in this class are the narcotics.

Narcotics, or opiates, such as morphine or codeine, are derived from the opium poppy; the synthetic narcotics (sometimes called opioids) include heroin, meperidine (Demerol), methadone, and fentanyl.

Hallocinogenics: Mescaline, LSD, and psilocybin

  • are examples of hallucinogenic drugs that alter an individual's perception, mood, and cognitive processes.

Psychotherapeutics: Prozac, Throazine.

  • Used to treat clinical disorders of mood or behaviour.


Dosage

  • Drug effects are related to drug concentration in the body, not just dosage.

    • One focus of the course = factors that change the relationship between dosage and drug concentration in the body.

    • Dosages are prescribed based on body weight (mg/kg).

    • mg/kg methods account for factors such as body composition and metabolic rate.

Dosage Response Curve (DRC)

  • Graph is used to display the amount of biological change in relation to a given drug dose.

  • Describes the extent of biological or behavioural effect (response in population) produced by a given drug concentration (dose).

  • A graph of the degree of drug response as a function of dosage

  • range from no effect to the highest effect

  • horizontal axis (x) =dose

  • vertical axis (y) =effect

  • e.g., the effect of alcohol on the rate of speech

When plotted on a semi-log scale, the curve takes on a classic S-shape. At low doses, the drug-induced effect is slight because very few receptors are occupied. As the dose of the drug is increased, more receptors are occupied, and a greater biobehavioral response occurs.

Dose Effect Curve

(sometimes also called the Does Response Curves)

  • required when a binary response variable is used

  • example, does aspirin completely stop a headache? (yes/no)

  • plot the percentage of each dosage group experiencing the given effect

  • ED 50 -median effective dose (effective in 50% of people)

  • LD 50 -median lethal dose (lethal in 50% of the population); usually based on animal research

  • TD 50 -median toxic dose(toxic in 50% of the population); provides crucial information for assessing the safety margin of a drug compared to its effectiveness.

  • Hyperreactors and hyporeactors are terms used to describe individuals who exhibit varying responses to a drug, where hyperreactors require lower doses for an effect, while hyporeactors need higher doses, complicating the understanding of individual dose-response relationships.

    • women who are pregnant, ethnicity, genes, and age.

    • e.g., caffeine can have differing effects based on these factors, with some individuals experiencing heightened sensitivity leading to adverse effects at lower doses. ‘

Drug Saftey

(uses dose-effect curves)

  • safer when LD is far from ED

  • Therapeutic Index (TI) = LD 50/ ED 50

  • Higher TI means a safer drug

  • Examples 1) LD 50 =100, ED 50 =5

    2) LD 50 =100, ED 50 =50

  • also: TI -TD 50/ED 50

  • Therapeutic drug monitoring protocols


Potency vs. Effectiveness

  • Describe the extent of a drug’s effects

Potency

  • A more potent drug has a lower ED 50

  • More potent drugs require less of the drug for the effect (but not necessarily clinically relevant) & likely have a greater affinity for the drug receptor.

  • Cheaper, safer, fewer side effects

Effectiveness

  • The drug that has the highest maximum effect is more effective


Primary Effect vs. Side Effect

Primary/Main/Therapeutic Effects

  • The effect for which the drug is taken.

Side Effects

  • Any other drug effects (harmful or beneficial), harmful effects = adverse effects.

Non-specific Drug Effects

  • Effects not due to the chemical activity of the drug but due to the person’s background (e.g., drug history), expectations, perceptions, attitudes, and other factors.

  • Placebo: expectations, but not because of the drug


Drug Interactions (Combining Drugs)

Agonistic- shifts the ED50 to the right; reduces the effect

  • Drug A, causes drug B to have less of a particular effect.

  • Naloxone antagonizes the effects of opioid

  • competitive antagonists; both drugs are trying to act on the same receptor.

  • non-competitive antagonists differ in that they reduce the effect of an agonist regardless of the concentration of the agonist at the receptor, often by binding to a different site on the receptor.

Competitive Antagonists:

  • A drug that binds to a receptor but has little or no efficacy. When it competes with an agonist for receptor sites, it reduces the effect of the agonist.

    • Naloxone on the analgesic effect of morphine. Naloxone can be overcome by increasing the amount of morphine administered.

Noncompetitive antagonists:

  • Drugs that reduce the effect of an agonist, but do not compete at the receptor site.

  • The drug may bind to an inactive portion of the receptor, disturb the cell membrane around the receptor, or interrupt the intercellular processes initiated by the agonist-receptor association.

Additive/Agonistic — drugs that have similar/equivalent effects; effects are higher than from either drug alone.

  • 20 mg drug A + 20 MG DRUG B =40 mg drug A

Superaddtive

  • shifts the Ed50 to the left, but the resultant effect is greater than the simple sum of the two drug effects (e.g., aspirin & phenytoin)

  • aka —potentiation; often involves pharmacokinetic effects (competition for depot binding - come back to this later).


Antagonists

Competitive antagonists —The 2 drugs compete to bind to the same receptors (e.g., naloxone & heroin).

  • Important tools in pharmacology

Noncompetitive antagonists —2 drugs do not compete to bind to the same receptor, but one drug impairs the binding of the other drug in another way.

Physiological antagonism —2 drugs have different mechanisms of action (not the same receptor), but they reduce each other’s effectiveness.


Lecture 2

Outline

  • Pharmacokinetics

    • Routes of administration

    • Absorbtion

    • Distributioon

    • Metabolism (Liver)

    • Elimination/Excretion (Kidneys)


Administration: What happens after the administration of a particular drug dose that leads to individual differences in the Drug Effects?

  • Pharmacokinetics and pharmacodynamics contribute to variability in the relationship between drug dose and response.

Pharmacokinetics:

  • Factors that contribute to the administration, absorption, distribution, inactivation/metabolism, and excretion of a drug.

  • Site of Action

    • Specific and limited places in the body where the drugs have been absorbed.

Routes of Administration

  • Methods used to get a drug from the outside of the body to some place under the skin.

  • Paternan:

    • Injections (IV, IM, IP, SC)

    • Inhaltion

      • Gases

      • Smoke and solids

    • Transdermal

  • Enteral: Gastrointestinal tract

    • Oral

    • Rectal


Injection Routes of Administration

  • Injection through the skin into different parts of the body using a hypodermic needle.

  • Vehicle

    • The liquid used to dissolve a drug so that it can be injected

    • Normal or physiological saline (0.9% sodium chloride)

  • Bolus

    • Small bubble of a drug and vehicle at the point of injection

  • Advantages

    • Simpler, unconscious, combative, not willing (naloxone), fast acting.

  • Disadvatages

    • Too much administered, overdose, infection, phobias.

  • Subcutaneous (s.c.)

    • Injection right under the skin (arm, thigh).

      • Hormonal contraceptives (Arm implant)

  • Intramuscular (i.m.)

    • Depot injections (anti psychotics) diffuse slowly out of the muscle, long acting.

    • Bigger muscles, slower absorption.

      • Antibiotics, biological (vax), hormones

  • Intraperitoneal (i.p.)

    • Paritanium (liver, spleen, intestines)

    • Used in animal research

  • Intravenous (i.v.)

    • The drug is injected directly into the bloodstream.

    • No fast pass metabolism

  • Other special injection methods:

    • intrathecal, intraventricular, intracranial, epidural, infusion pump under scalp, viral vectors (future).

  • Intercranial

  • Epidural

    • Ceriberal spinal

    • Directly into the brain

  • Infusions pump

    • Brain infection

  • Viral vectors

    • gene therapy, injects viruses that contain DNA to encode certain protein.


Absorption from Injection Sites (Stages)

  • Absorption affected by:

    • volume of blood flow to an area

    • exercise

    • temperature

  • R Heart —> Arteries —> Capillaries —> Veins —> L Heart

  • Capillaries

    • permeates most body tissues because it allows nutrients and oxygen to get to different parts of the body.

    • drugs get into the bloodstream through capillary walls throuhg diffusion.


Inhalation of Gases -bypassing first pass metabolism

  • The body has a good system for taking oxygen from the air and distributing it quickly through the circulatory system.

  • Lungs

    • Large surface area; large # capillaries

    • Inhaled gases are directly absorbed through capillary walls and transported to the heart and brain.

    • A main artery goes from the heart to the brain.

  • Diffusion (controls dosage)

Inhalation of Smoke & Solids

  • Burn material and inhale active materials in the smoke or aash

  • Drugs dissolve on the moist surfaces of the lungs and diffuse into the blood (e.g., tobacco smoke). Nicotine dissolves on the moist surfaces of the lungs, then diffuses into the blood.

  • Vaping is considered an aristol??


Transdermal Administration

  • Epidermis

    • layer of skin that is the main barrier to absorption

    • packed with keratin

    • only penetrated by lipid-soluble substances (dissolve easily in lipids or fat).

    • Methlyphenidate (Treat ADHD)

  • E.g., nicotine patch, hormonal contraceptive patch, HT, hormone patches for menopause, anti-depressant patches.

  • for small lipophillic (dissolves in fat) miolecules that can passively diffuse trhough skin.

  • Transdermal vaccination delivery (pandemics)

  • Ultrasound-enhanced transdermal delivery (to increase pore size of skin).


Topical

  • Applied to mucous membrane (eyes, oral cavity, ears, nasopharynx, vagine, colon, urethra, rectum).

  • buccal membranes of the mouth (into the blood) (floor of the mouth, cheeks, gums/gingiva, palatal mucosa, lining of the lips).

  • Faster effect, doesn’t pass through metabolism.

  • Intranasal administration

    • tobacco snuff, cocaine, nicotine spray

    • lungs or mucous membranes to the blood or the digestive system


Enteral Routes

Rectal Administration

  • Suppositories can be placed in the rectum and are absorbed into the blood through the digestive system.

  • Can avoid some first-pass metabolism

  • Lower rectum - drug goes into the portal vein (goes to the liver before general circulation).

  • Upper rectum - drug goes into the portal vein (goes to the liver before general circulation).


Oral Administration

  • P.o. peroral

  • digestive system (stomach, intestines best absorbs the drug)

  • Related routes

    • Intranasal can get into the digestive system

    • Buccal membranes of the mouth (into the blood)


First Pass Metabolism: blood circulation from the GI tract goes directly to the liver (via portal vein) before going to the blood that supplies the body and brain; due to enzymes in the GI tract and hepatic portal system, the oral route results in lower drug levels eventually reaching the brain.


The Digestive System

  • intestines are lined with capillaries to absorb nutrients from food.

  • The faster the drugs get to the intestines = the faster absorption

  • Most drugs are not fully absorbed until they reach the small intestine.

  • Lipid barrier between food (or frug) and blood (i.e., cell membranes)

  • A drug passes through the cell membrane to get into the blood.

  • Lipid solubility

    • determines absorption and speed of entry into the blood and brain

    • measured by the oil/water partition coefficient

  • Factors that determine lipid solubility

    • properties of the drug

    • degree of ionization (electric charge) (ions are not lipid soluble)


pH

pH is important to understand as pH (of the drug, the digestive system, and the blood) affects ionization, lipid solubility, and rates of absorption.


Determinants of Ionization

1) pH of solvent (is the drug dissolved in acid or base?)

2) whether the drug is a weak acid or a weak base

3) pKa of the drug

  • The pH at which half of its molecules are ionized

    • drugs are generally more ionized in a solvent with an opposite pH (e.g., acids are more ionized in basic/alkaline solutions; bases are ionized in

  • The percentage of ionization determines the rate of absorption.


Ion Trapping

  • The tendency for acidic drugs to get trapped on the basic side of the membrane and basic drugs to get trapped on the acidic side of the membrane.

  • Only nonionized molecules can diffuse through the membrane (until equal concentration on both sides)


Drug Distribution

  • Where the drugs go in the body

  • Concentrated in places with the highest blood flow (heart, brain, kidneys, liver)

  • Factors Affecting

1./ Lipid Solubility

  • Highly lipid-soluble drugs tend to concentrate in the lipids (body fat), are inactive, released slowly.

    • Cannabis can test positive on a drug test a month later.

  • Water-soluble drugs concentrate in body water.

  • Most drugs are inactive when in body fat.

2./ Active & Passive Trasport

  • Passive transport mechanisms

    • a non-lipid soluble molecule may attach itself to a molecule that readily diffuses across the membrane 9high to low)

  • Active transport mechanisms

    • works against normal diffusion

    • energy expended to move molecules from low to high concentrations.

    • Drug receptors are often on the outside of cells (hormone receptors are inside cells).

3./ The three Barriers:

  • Blood Brain Barrier:

    • Special cells in the CNS that wrap themselves around capillaries and block the pores through which drugs normally diffuse; selectively permeable.

  • Placental Barrier

    • Lipid-soluble drugs cross more easily

    • Fetuses’ blood levels of all drugs reach 75-100% of the mother’s in 5 min.

    • Generally, all psychoactive drugs will be present in featu’s blood supply

  • Depot or Protein Binding (e.g., albumin)

    • Large protein molecules in blood cannot diffuse through capillaries

    • Some drugs bind to them and cannot exert while bound

    • drugs also bind to muscle fat (inactive sites = depot sites) (e.g., THC)

    • Individual differences in depot binding account for differences in sensitivity to drugs

    • Protein binding can cause drug interactions (anticonvulsant phenytoin binds to proteins, but aspirin binds more readily and displaces it, raising phenytoin blood levels).



Placental Barrier

  • Generally, all psychoactive drugs will be present in the fetus at a concentration similar to that in the mother’s bloodstream.


Metabolism and Excretion (Drug Fate)

  • How the body gets rid of the drug (liver, kidney, skin through sweat).

  • The speed of these 2 processes determines the duration of he drug’s effects.


Organs Involved

  • Liver

    • primarily involved in metabolism/biorransformation

    • Intestins, kidneys, lungs, and skin can also play a role in metabolism.

  • Kidney

    • primarily involved in excretion

    • but intestines/bile (feces), lungs (saliva), and skin (sweat) can also play a role. Most drugs leave the body through urine.

  • Liver cells = hepatocytes

    • Chemical factory controlled by enzymes (primarily on the smooth endoplasmic reticulum)

    • Breaks down drugs into ions, which are more easily excreted by the kidneys

  • Enzyme

    • Catalyst, ends in “ase”

    • speeds up chemical reactions

    • Example: alcohol dehydrogenase

  • Prodrug

    • The drug doesn’t help until it’s metabolized.

    • Aldopa (dopamine drug), Vivance (ADHD).

  • Kidneys

    • filters everything out and reabsorbs what is needed and what is soluble

    • The nephron is the functional unit of the kidney

    • Reabsorption (into blood) is already pH

      • Manipulation of urine pH can affect excretion (ion-trapping -bases are generally excreted)

      • Acidic drugs - sodium bicarbonate

      • Basic drugs - iv ammonia chloride


First Pass Metabolism

  • metabolism before the drug is fully absorbed

  • It can occur in drugs that pass through the digestive system

  • Drug molecules that are absorbed from he digestive system pass into he blood that goes to the liver before


5 Factors that Alter Drug Metabolism

  • Stimulation of Enzyme Systems

    • a.k.a. enzyme induction

    • Previous exposure to a specific drug that uses that enzyme can lead to higher levels of that enzyme

    • Metabolic toeralnce

    • Example: alcohol dehydrogenase, people who drink alcohol tend to have higher levels of alcohol dehydrogenase.

    • Some drugs use the same enzyme systems.

  • Depression of Enzyme Systems

    • When two drugs that require the same enzymes for metabolism are taken simultaneously, the metabolism of each will be depressed.

    • Competition for enzymes.

    • Example: alcohol & Antabuse ( for quitting alcohol, makes you sick if you drink) both require aldehyde dehydrogenase.

  • Age

    • Babies and elderly people often have poor metabolism

    • The metabolism of specific drugs seems to change with age

  • Genetic Polymorphisms

    • Genetic differences between people can lead to differences in the production of drug-metabolizing enzymes.

    • e.g., caffeine - slow metabolizers have higher risks of heart attack with coffee intake.

    • Carriers of the CYP1A2×1F allele

  • Species

    • Example - alcohol dehydrogenase

      • Guinea pig > human > rat/mouse

    • Phenylbutazone (treats race horses)

      • Half-lives: 3.6 hours vs. 3 days


Cytochrome P450 Enzyme Family

  • The major system involved in drug metabolism (e.g., alochol, tranquilizers, barbituaretes, antiaziety drugs, androgen, estrogen, PCBs).

  • Exposure to any of the above substances is associated with an increased production og CYP-450 (enzyme induction)

  • Other substances can inhibit enzymes (e.g., buspirone) (BuSpar) and grapefruit juice (furanocoumarin - inhibits CYP-3A4).

  • CYP-3A4 catalyzes about 50% of drug biotransformations, with CYP-2D^ and CYP2C each catalyzing about 20% more.


Drug Clearance & Rate of Excretion

  • Fastest when blood levels of drugs are high

    • First order kinetics — exponential elimination (constant fraction removed per time period), most drugs.

    • Exception: Zero-order kinetics — drug cleared at a constant rate regardless of concentration (alcohol - 1.0 oz of 100 proof alcohol per hour).

  • Half-Life (t 1/2)

    • time taken to reduce drug concentration in blood by 50%

    • Usually takes 6 half-lives for 98% of dthe rug to be eliminated.

    • Ideal t ½ for a drug taken 1x/day is 8 hours (88% eliminated in 24 hours).


Other Non-specific Factors that may affect drug response

  • Weighs

  • Sex and hormonal status

  • diesease

  • nutrition

  • biorhytms